Related Experiment Videos

Pemphigus serum-induced loss of microvilli from human epidermal cells

Insights

Pemphigus sera cause human epidermal cells to lose surface microvilli, potentially leading to acantholysis. Protease inhibitors can prevent this microvilli loss, suggesting enzymes play a key role.

Area of Science:

  • Dermatology
  • Cell Biology
  • Immunology

Background:

  • Pemphigus is an autoimmune blistering disease affecting the skin.
  • Acantholysis, the loss of cell adhesion in the epidermis, is a hallmark of pemphigus.
  • The precise mechanisms underlying pemphigus pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the effect of pemphigus sera on human epidermal cell surface morphology.
  • To determine the role of microvilli loss in pemphigus-induced acantholysis.
  • To explore the involvement of proteolytic enzymes in pemphigus pathogenesis.

Main Methods:

  • Scanning electron microscopy (SEM) was used to examine human epidermal cells.
  • Cells were prepared from suction blister roofs and treated with trypsin and dithioerythritol.
  • Cells were incubated with pemphigus sera or control sera, with and without complement or protease inhibitors.

Main Results:

  • Pemphigus sera significantly reduced the presence of surface microvilli on epidermal cells compared to control sera (p < 0.001).
  • The loss of microvilli was not influenced by the presence of complement.
  • A protease inhibitor (ovomucoid) significantly inhibited the pemphigus-induced loss of microvilli (p < 0.001).

Conclusions:

  • The loss of epidermal cell microvilli induced by pemphigus sera may contribute to acantholysis.
  • Proteolytic enzymes are likely involved in the smoothing of the epidermal cell surface observed in pemphigus.
  • These findings suggest a potential therapeutic target for pemphigus by inhibiting proteolytic enzymes.

Related Concept Videos